Financhill
Sell
30

VOR Quote, Financials, Valuation and Earnings

Last price:
$14.54
Seasonality move :
-16.93%
Day range:
$13.39 - $15.27
52-week range:
$2.62 - $65.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.13x
Volume:
850.5K
Avg. volume:
2.6M
1-year change:
-16.92%
Market cap:
$99.4M
Revenue:
--
EPS (TTM):
-$381.91

Earnings Data

Next earnings date for VOR
Mar 26
2026
Most recent earnings per share
-$121.63
Missed by $117.53
(Nov 13/2025)
Consensus Estimate
-$4.10
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VOR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/26/2026 Q4 -- -- -- -$0.97 --
11/13/2025 Q3 -- -- -$121.63 -$4.10 -$117.53
08/13/2025 Q2 -- -- -$251.24 -$11.80 -$239.44
05/08/2025 Q1 -- -- -$0.26 -$4.16 $3.90
03/20/2025 Q4 -- -- -$8.78 -$6.13 -$2.65
11/07/2024 Q3 -- -- -$0.40 -$8.09 $7.68
08/08/2024 Q2 -- -- -$0.41 -$8.29 $7.88
05/09/2024 Q1 -- -- -$0.45 -$7.63 $7.18
03/20/2024 Q4 -- -- -$0.39 -$9.94 $9.56
11/07/2023 Q3 -- -- -$0.49 -$9.17 $8.68
08/10/2023 Q2 -- -- -$0.45 -- --
05/11/2023 Q1 -- -- -$0.43 -- --
03/23/2023 Q4 -- -- -$0.51 -- --
11/10/2022 Q3 -- -- -$0.63 -- --
08/11/2022 Q2 -- -- -$0.58 -- --
05/12/2022 Q1 -- -- -$0.61 -- --
03/14/2022 Q4 -- -- -$0.49 -- --
11/10/2021 Q3 -- -- -$0.50 -- --
08/09/2021 Q2 -- -- -$0.50 -- --
05/06/2021 Q1 -- -- -$0.41 -- --
12/31/2020 Q4 -- -- -$0.48 -- --
09/30/2020 Q3 -- -- -$0.38 -- --
06/30/2020 Q2 -- -- -$0.24 -- --
03/31/2020 Q1 -- -- -$0.23 -- --
12/31/2019 Q4 -- -- -$0.12 -- --
09/30/2019 Q3 -- -- -$0.11 -- --

Vor Biopharma, Inc. Earnings Questions

  • How Much did Vor Biopharma, Inc. Generate in Revenue Last Quarter?

    Vor Biopharma, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Vor Biopharma, Inc. Beat Earnings Last Quarter?

    Vor Biopharma, Inc. announced earnings per share of -$121.63 which represents a miss of analyst forecast a -$4.10 per share.

  • Is Vor Biopharma, Inc. Profitable?

    Vor Biopharma, Inc. reported -$2K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Vor Biopharma, Inc. EPS Next Year?

    Vor Biopharma, Inc.'s earnings are forecast to decrease from -$34.03 per share to -$29.27 per share next year representing a decrease of -203.08%.

  • When is Vor Biopharma, Inc.'s Earnings Date?

    Vor Biopharma, Inc.'s next earnings date is March 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock